OTLK Intrinsic Valuation and Fundamental Analysis - Outlook Therapeutics Inc

	Outlook Therapeutics Inc NASDAQ:OTLK	US
	VSE Corp F:VS3	US

Intrinsic Value

The intrinsic value for Outlook Therapeutics Inc (OTLK) under the Base Case is 2.1122 USD. Compared with the current market price of 0.6612 USD, the stock appears Undervalued by 69% .

Intrinsic value calculated using Multiples

$2.1122

Other reference points

Wall St target

$5.508

Do our valuations actually work? See backtest results .

OTLK Intrinsic Value

Undervaluation 69%

Intrinsic Value

Price $0.6612

Loading...

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value $1.69

Get notified when the price drops into your buy zone

Intrinsic Value $2.11

Margin of Safety 20% $1.69

Current Price $0.66

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Outlook Therapeutics Inc.

Explain Valuation